ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 428 filers reported holding ENCOMPASS HEALTH CORP in Q3 2018. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $109 | -99.7% | 1,621 | +118.2% | 0.02% | +90.0% |
| Q3 2022 | $34,000 | -19.0% | 743 | 0.0% | 0.01% | -16.7% |
| Q2 2022 | $42,000 | -19.2% | 743 | 0.0% | 0.01% | +9.1% |
| Q1 2022 | $52,000 | +6.1% | 743 | 0.0% | 0.01% | +37.5% |
| Q4 2021 | $49,000 | +1533.3% | 743 | +1480.9% | 0.01% | +700.0% |
| Q3 2021 | $3,000 | 0.0% | 47 | 0.0% | 0.00% | – |
| Q2 2021 | $3,000 | -94.4% | 47 | -92.9% | 0.00% | -100.0% |
| Q1 2021 | $54,000 | -46.0% | 661 | -45.7% | 0.01% | -44.4% |
| Q4 2020 | $100,000 | +316.7% | 1,217 | +230.7% | 0.01% | +350.0% |
| Q3 2020 | $24,000 | -69.6% | 368 | -71.0% | 0.00% | -71.4% |
| Q2 2020 | $79,000 | -25.5% | 1,271 | -23.8% | 0.01% | -41.7% |
| Q1 2020 | $106,000 | +171.8% | 1,669 | +229.8% | 0.01% | +200.0% |
| Q4 2019 | $39,000 | -81.6% | 506 | -81.4% | 0.00% | -88.9% |
| Q3 2018 | $212,000 | +98.1% | 2,714 | +72.1% | 0.04% | +111.8% |
| Q2 2018 | $107,000 | – | 1,577 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |